Induction of Sister-chromatid Exchanges,Micronuclei and Gene Mutations by Indirectly Acting Promutagens Using Human Hepatoma Cells as an Activation System
Restricted accessResearch articleFirst published online November, 1994
Induction of Sister-chromatid Exchanges,Micronuclei and Gene Mutations by Indirectly Acting Promutagens Using Human Hepatoma Cells as an Activation System
An established human hepatoma cell strain (designated Hep G2) was used in sister-chromatid exchange (SCE) and micronuclei (MN) assays to study, in vitro, the genotoxic potentials of indirectly acting promutagenic carcinogens, such as 2-acetylaminofluorene (2-AAF) and hexamethylphosphoramide (HMPA), and a non-carcinogen, 4-acetylaminofluorene (4-AAF). In addition, Hep G2 S9-fractions were isolated and used to activate the same chemicals using Chinese hamster ovary (CHO) cells as target cells in vitro. The percentage survival and the frequencies of MN, SCEs and point mutations (at the HPRT locus) were used as biological endpoints.
A dose-dependent increase in the frequencies of SCEs, MN, cytotoxicity, and/or point mutations was found in Hep G2 cells, and in CHO cells in the presence of Hep G2 S9-fractions, with 2-AAF and HMPA, but with 4-AAF no increase was found. The results obtained demonstrate that the Hep G2 cells and their S9-fractions are capable of activating different classes of mutagens to form biologically active metabolites.
MailingH.V. (1966). Mutagenicity of two potent carcinogens, dimethylnitrosamine and diethyl-nitrosamine, in Neurospora crassa.Mutation Research3, 537–540.
2.
WrightA.S. (1980). The role of metabolism in chemical mutagenesis and chemical carcinogenesis.Mutation Research75, 215–241.
3.
AmesB.N., DurstonW.E., YamasakiE., and LeeF.D. (1973). Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection.Proceedings of the National Academy of Sciences of the United States of America70, 2281–2285.
4.
NatarajanA.T., TatesA.D., van BuulP.P.W., MeijersM., & de VogelN. (1976). Cytogenetic effects of mutagens/carcinogens after activation in a microsomal system in vitro. I. Induction of chromosome aberrations and sister-chromatid exchanges by diethylnitrosamine (DEN) and dimethylnitrosamine (DMN) in CHO cells in the presence of rat-liver microsomes.Mutation Research37, 83–90.
5.
BosE.P., NeisJ.M., van GemertP.J.L., and HendersonP.T. (1983). Mutagenicity testing with the Salmoraella/hepatocyte and the Salmonella microsome assays. A comparative study with some known genotoxic compounds.Mutation Research124, 103–112.
6.
AshbyJ., and RichardsonC.R. (1985). Tabulation and assessment of 113 human surveillance cytogenetic studies conducted between 1965 and 1984.Mutation Research154, 111–133.
7.
PurchaseL.F.H., and RayV. (1981). Summary reports on the performance of in vivo assays. In Evaluation of Short-Term Tests for Carcinogens, Vol. 1 (ed. de SerresF.J., & AshbyJ.), pp. 86–95. New York: Elsevier.
8.
TakehisaS., and WolffS. (1977). Induction of sister-chromatid exchanges in Chinese hamster cells by carcinogenic mutagens requiring metabolic activation.Mutation Research45, 263–270.
9.
NatarajanA.T., & van kesteren van-LeeuwenA.C. (1981). Mutagenic activity of 20 coded compounds in chromosome aberrations/sisterchromatid exchange assay using Chinese hamster overy (CHO) cells. In Evaluation of Short-Term Tests for Carcinogens (ed. de SerresF.J., & AshbyJ.), pp. 551–558. New York: Elsevier.
10.
PalittiF., FioreM., de SalviaR., TanzarellaC., RicordyR., ForsterR., MossesoP., AstolfiS., and LoprienoN. (1985). Tests for induction of chromosomal aberrations in Chinese hamster ovary (CHO) cells in culture. In Evaluation of Short-Term Tests for Carcinogens, Vol. 5 (ed. AshbyJ., de SerresF.J., DraperM., IshidateM.Jr., MargolinB.H., MatterB.E., ShelbyM.D.), pp. 443–450. New York: Elsevier.
11.
NatarajanA.T., de BruinE.A., LeeflangP., SleeP.H.T.J., MohnG.R., and DriessenO. (1983). Induction of chromosomal aberrations as an assay for cytostatic drug activity in plasma.Mutation Research121, 39–45.
12.
DarroudiF., and NatarajanA.T. (1985). Cytostatic drug activity in plasma, a bioassay for detecting mutagenicity of directly and indirectly acting chemicals, an evaluation of 20 chemicals.Mutation Research143, 263–269.
13.
DarroudiF., TargaH., and NatarajanA.T. (1988). Influence of dietary carrot on cytostatic drug activity of cyclophosphamide and its main directly acting metabolite: induction of sister-chromatid exchanges in normal human lymphocytes, Chinese hamster ovary cells, and their DNA repair-deficient cell line.Mutation Research198, 327–335.
14.
DarroudiF., and NatarajanA.T. (1987). Induction of chromosomal aberrations and sister-chromatid exchanges in CHO cells by mutagenic metabolites activated by plant microsomal extracts.Biological Zentral Blad106, 169–174.
15.
CrespiC.L., LangenbachR., and PenmanB.W. (1989). The development of a panel of human cell lines expressing specific human cytochrome P450 cDNA. In Mutation and the Environment, Vol. 340D (ed. MendelsohnM.L., AlbertiniR.L.), pp. 97–106. New York: Alan R. Liss.
16.
KasperP., MadleS., and GeorgeE. (1988). Induction of SCE by indirect mutagens in cultured rat hepatoma cells and in Chinese hamster V79 cells co-cultivated with hepatocyte primary cultures.Mutagenesis6, 521–525.
17.
SalviaR., de MeschiniR., FioreM., PolaniS., PalittiF., CarluccioM.A., and TurchiG. (1988). Induction of sister-chromatid exchanges by pro-carcinogens in metabolically competent Chinese hamster epithelial liver cells.Mutation Research207, 69–74.
18.
TurchiG., CarluccioM.A., GlattH.R., Gemperlein-MertesI., and OeschF. (1987). Characterization of an epithelial cell strain from Chinese hamster.Mutagenesis2, 127–135.
19.
SalissidisC., KulkaU., SchmidE., PaulD., and BauchingerM. (1991). Induction of chromosome aberration and sister chromatid exchange by indirectly acting mutagens in immortal mouse and rat hepatocyte lines.Mutagenesis6, 59–63.
20.
ChipmanJ.K., DaviesJ.E., and PatersonP. (1987). Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylamino-fluorene mutagenicity in rat and human heyatocytes/Salmonella assays.Mutation Research187, 105–112.
21.
NatarajanA.T., and DarroudiF. (1991). Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens.Mutagenesis6, 399–403.
22.
GlattH.R., UteschandD., and OeschF. (1984). Hepatocyte- but not S9-mediated mutagenicity correlates with the carcinogenicity of methyl-benz(a)anthracenes. In Polynuclear Aromatic Hydrocarbons: Mechanisms, Methods and Metabolism (ed. CookeM., DennisA.J.), pp. 475–484. Columbus, OH, USA: Battelle Press.
23.
DarroudiF., and NatarajanA.T. (1993). Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro): Mutagenesis8, 11–15.
24.
PerryP.E., and WolffS. (1974). New Giemsa method for differential staining of sister-chromatids.Nature (London)251, 156–158.
25.
LowryO.H., RosebroughN.J., FarrA.L., and RandallF.J. (1951). Protein measurement with Folin phenol reagent.Journal of Biological Chemistry62, 315–323.
26.
McCannJ.E., ChoiE., YamasakiE., and AmesB.N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.Proceedings of the National Academy of Sciences of the United States of America72, 5135–5139.
27.
LaneA.M., PhilipsB.J., and AndersonD. (1985). Tests for the induction of sister-chromatid exchanges in Chinese hamster ovary. (CHO) cells in culture. In Evaluation of Short-Term Tests for Carcinogens, Vol. 5 (ed. AshbyJ., de SerresF.J., DraperM., IshidateM.Jr., MargolinB.H., MatterB.E., ShelbyM.D.), pp. 451–455. New York: Elsevier.
28.
KrahnD.F., and HeidelbergerC. (1976). Liver-homogenate mediated mutagenesis in Chinese hamster V79 cells by chemical carcinogens.Mutation Research38, 399–400.
29.
GonzalezF.J. (1989). The molecular biology of cytochrome P450s.Pharmacology Review40, 243–287.
30.
MilesJ.S., and WolfC.R. (1991). Developments and perspectives on the role of cytochrome P450s in chemical carcinogenesis.Carcinogenesis12, 2195–2199.
31.
DograS., DoehmerJ., GlattH., MoldersH., SiegertP., FriedbergT., SiedellA, & OeschF. (1990). Stable expression of rat cytochrome P4501A1 cDNA in V79 hamster cells and their use in mutagenicity testing.Molecular Pharmacology37, 608–613.
32.
CrespiC.L., GonzalezF.J., SteimelD.T., TurnerT.R., GelboinH.V., PenmanB.W., and LangenbachR. (1991). A metabolically competent human cell line expressing five cDNA encoding procarcinogen-activating enzymes: application to mutagenicity testing.Chemical Research in Toxicology4, 566–572.
33.
EllardS., MohammadY., DograS., WolfelC., DoehmerJ., and ParryJ.M. (1991). The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNA in micronucleus assays.Mutagenesis6, 461–470.
34.
GlattH.R., GemperleinI., SetiabudiF., PlattK.L., and OeschF. (1990). Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds.Mutagenesis5, 241–249.
35.
SwadaM., KitamuraR., and KamatakiT. (1992). Stable expression of monkey cytochrome P4501A1 cDNA in Chinese hamster CHL cells and its application for detection of mutagenicity of aflatoxin B1.Mutation Research265, 23–29.
36.
CrespiC.L., PenmanB.W., StiemelT., GelboinH.V., and GonzalezF.J. (1991). The development of human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparisons to CYP1A2 and CYP2A3.Carcinogenesis12, 355–359.
37.
DearfieldK.L., Jacobson-KramD., HuberB.E., and WilliamsJ.R. (1986). Induction of sister-chromatid exchanges in human and rat hepatoma cell lines by cyclophosphamide and phosphoramide mustard and the effect of cytochrome P450 inhibitors.Biochemical Pharmacology13, 2199–2205.
